Skip to main content
Premium Trial:

Request an Annual Quote

Hershel Safer, Eric Eastman, Martin Hollenhorst, Klaus Sprockamp

Premium

Hershel Safer, formerly a research scientist at Tel Aviv-based Compugen, has been tapped to head the bioinformatics department at Zetiq Technologies, a Rehovot, Israel-based biotechnology company developing non-cytotoxic anti-cancer drugs.

 

Morphochem of Munich, Germany, has appointed Eric Eastman to the newly created position of president of Morphochem Inc. He will also run the company’s research facility in Monmouth Junction, NJ. Eastman was previously senior vice president and CTO at Gaithersburg, Md.-based Gene Logic, where he managed the company’s R&D activities and its technology portfolio.

 

Lion Biosciences said it has appointed Martin Hollenhorst as the company’s new CFO. Hollenhorst, who most recently worked as a freelance management consultant in Washington, DC, will join the Heidelberg, Germany-based company on April 1. Hollenhorst’s experiences include serving as CEO of ANN Systems ASA, a German-American software company. He replaces Lion’s former CFO Klaus Sprockamp, who was lost in the Sept. 11 attacks on the World Trade Center in NewYork.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.